Associate Director, CMC

Fusion Pharmaceuticals, part of the AstraZeneca Group, is redefining precision oncology with next‑generation radioconjugates that deliver powerful alpha‑emitting payloads directly to tumors. Our pipeline spans multiple first‑in‑class programs—backed by a GMP‑compliant, state‑of‑the‑art radiopharmaceutical facility in Hamilton, we’re turning cutting‑edge science into real‑world impact for patients. Join us at the forefront of radiopharma innovation and be part of turning breakthrough science into meaningful outcomes for patients—come build what’s next with us!

The Role

This role leads end-to-end execution of AstraZeneca’s manufacturing strategy for radiopharmaceutical conjugates, owning CDMO selection and management for process development, optimization, tech transfer, and cGMP manufacturing of precursor materials from preclinical through commercialization, in full compliance with cGMP, ICH, and FDA expectations. The leader proactively identifies process gaps and C...